Edward W. Withrow III - 31 Dec 2012 Form 5/A - Amendment Insider Report for PARALLAX HEALTH SCIENCES, INC.

Reporting relationship: Director, 10%+ Owner
Issuer ticker: N/A
Reported as of: 31 Dec 2012
Net transaction value: +$56,509
SEC form: 5/A - Amendment
Accepted by SEC: 17 Mar 2022, 15:56:06 UTC
Original report date: 07 Jan 2014
Next SEC filing: 04 Mar 2022
Source filing: View source filing
Reporting owner signature: EDWARD W. WITHROW III

Key filing fact

Edward W. Withrow III filed Form 5/A - Amendment for PARALLAX HEALTH SCIENCES, INC. on 17 Mar 2022.

Key facts

This page summarizes Edward W. Withrow III's Form 5/A - Amendment filing for PARALLAX HEALTH SCIENCES, INC..
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 17 Mar 2022, 15:56.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$56,509.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRLX transaction

COMMON STOCK

Other

Transaction value: $7,631
Shares: +7,631,245
Change %
Price: $0.001000^*
Shares after: 7,631,245
Date: 06 Dec 2012
Ownership: Direct
Footnotes: F1

PRLX transaction

COMMON STOCK

Other

Transaction value: $5,000
Shares: +5,000,000
Change %: +66%
Price: $0.001000^*
Shares after: 12,631,245
Date: 06 Dec 2012
Ownership: By Spouse
Footnotes: F1

PRLX transaction

COMMON STOCK

Other

Transaction value: $5,722
Shares: +5,721,900
Change %: +45%
Price: $0.001000^*
Shares after: 18,353,145
Date: 06 Dec 2012
Ownership: By Withrow Sinclair & Co.
Footnotes: F1

PRLX transaction

COMMON STOCK

Other

Transaction value: $38,156
Shares: +38,156,227
Change %: +208%
Price: $0.001000^*
Shares after: 56,509,372
Date: 06 Dec 2012
Ownership: By Montecito BioSciences Ltd.
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares issued in connection with an agreement and plan of merger dated November 1, 2012.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .